Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Talpaz

Showing results (151-160 of 350) with videos related to

Pageof 35
Sort By:
Cancer|August 15, 1995
Transformation of chronic lymphocytic leukemia to lymphoma of true histiocytic typeM Wetzler, R Kurzrock, A M Goodacre, et al.
The American Journal of Medicine|April 1, 1996
Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and olderJ Cortes, H Kantarjian, S O'Brien, et al.
Acta Haematologica|January 1, 1990
Alpha interferon dose-dependent suppression of secondary clones in a patient with Philadelphia-positive chronic myelogenous leukemiaD Claxton, H Kantarjian, R Kurzrock, et al.
Blood|November 1, 1991
Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progressionM Wetzler, R Kurzrock, D G Lowe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
A phase I study of recombinant interferon-beta in patients with advanced malignant diseaseF Ravandi, Z Estrov, R Kurzrock, et al.
Blood|March 1, 1987
Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patientsJ S Lee, D O Dixon, H M Kantarjian, et al.
Cancer|August 1, 1997
Thiotepa for the treatment of thrombocythemia in patients with Philadelphia chromosome positive chronic myelogenous leukemiaE J Rodriguez-Monge, J E Cortes, S O'Brien, et al.
Virology|January 30, 1985
The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activityW Kloetzer, R Kurzrock, L Smith, et al.
The American Journal of Medicine|January 1, 1990
Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemiaH M Kantarjian, M J Keating, T L Smith, et al.
JAMA|September 13, 1985
Immune thrombocytopenia following alpha-interferon therapy in patients with cancerP McLaughlin, M Talpaz, J R Quesada, et al.
Pageof 35

Showing results (151-160 of 350) with videos related to

Sort By:
Pageof 35
Cancer|August 15, 1995
Transformation of chronic lymphocytic leukemia to lymphoma of true histiocytic typeM Wetzler, R Kurzrock, A M Goodacre, et al.
The American Journal of Medicine|April 1, 1996
Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and olderJ Cortes, H Kantarjian, S O'Brien, et al.
Acta Haematologica|January 1, 1990
Alpha interferon dose-dependent suppression of secondary clones in a patient with Philadelphia-positive chronic myelogenous leukemiaD Claxton, H Kantarjian, R Kurzrock, et al.
Blood|November 1, 1991
Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progressionM Wetzler, R Kurzrock, D G Lowe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
A phase I study of recombinant interferon-beta in patients with advanced malignant diseaseF Ravandi, Z Estrov, R Kurzrock, et al.
Blood|March 1, 1987
Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patientsJ S Lee, D O Dixon, H M Kantarjian, et al.
Cancer|August 1, 1997
Thiotepa for the treatment of thrombocythemia in patients with Philadelphia chromosome positive chronic myelogenous leukemiaE J Rodriguez-Monge, J E Cortes, S O'Brien, et al.
Virology|January 30, 1985
The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activityW Kloetzer, R Kurzrock, L Smith, et al.
The American Journal of Medicine|January 1, 1990
Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemiaH M Kantarjian, M J Keating, T L Smith, et al.
JAMA|September 13, 1985
Immune thrombocytopenia following alpha-interferon therapy in patients with cancerP McLaughlin, M Talpaz, J R Quesada, et al.
Pageof 35